Orion stock gains as analysts keep a 76.67 EUR target

Published on 09/07/2026 at 19:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Orion stock trades near 39.60 EUR as MarketScreener shows a 25.32 percent gain for 2026 and analysts keep a 76.67 EUR average target.

Moderne Pharmaproduktionsanlage bei Tageslicht, Orion Oyj FI0009014377 — Fotorealistisches Bild zeigt moderne Pharmafabrik von Orion Oyj, ISIN FI0009014377, mit Produktionsanlagen in Finnland, Illustration mit AI erstellt.

Orion stock (FI0009014377) traded at 39.60 EUR on September 7, 2026, after a 0.50 percent daily decline, while MarketScreener showed a 25.32 percent gain for 2026 and a 52-week range of 31.60 EUR to 41.00 EUR.MarketScreener The same source lists an average analyst target of 76.67 EUR and 6 analysts covering the name.

Half-year numbers still set the tone

For Orion Oyj, the most recent reported figures in the search set are the first-half 2026 numbers: revenue reached 905.7 million EUR, the second quarter revenue was 471.3 million EUR, and net debt stood at 89.8 million EUR in the 2026 forecast set on MarketScreener.MarketScreener The same page shows a 2026 forecast margin profile with EBITDA margin at 36.83 percent and EBIT margin at 33.83 percent, which frames the stock as a margin story as much as a sales story.

Price still trails targets

The gap is concrete: the 39.60 EUR quote on September 7, 2026 sat 3.93 percent below the 76.67 EUR consensus target, even after the stock had already advanced 25.32 percent in 2026.MarketScreener That makes valuation and earnings delivery the key test, not the day-to-day move.

Own shares add a second driver

MarketScreener also noted on August 27, 2026 that Orion started a repurchase program for its share-based incentive plans, and a Via Ritzau filing on September 1, 2026 showed an Orion share transaction at 79.6200 EUR for 26,962 shares worth 2,146,714.60 EUR.Via Ritzau For investors, that combination keeps capital allocation and share count in view alongside operating performance.

Pharmaceutical mix matters

Orion is a Finnish pharmaceuticals group with revenue split across innovative medicines, generic and consumer medicines, branded prescription products, animal health and pharmaceutical ingredients. The company profile on MarketScreener also lists about 4,000 employees and a 19. October dividend date of 0.9 EUR.

Stock near the yearly band

At 39.60 EUR on September 7, 2026, Orion stock sat close to the upper end of its 52-week band of 31.60 EUR to 41.00 EUR on MarketScreener, with a year-to-date move of 25.32 percent.MarketScreener